Page 5 - உலகளாவிய தலை ஆஃப் பெருநிறுவன தகவல்தொடர்புகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

EmployBridge to be Acquired by Apollo Funds

NEW YORK and ATLANTA, June 03, 2021 (GLOBE NEWSWIRE) Apollo Global Management, Inc. (NYSE:APO) (together with its consolidated subsidiaries, "Apollo") .

United statesQuiana pinckneyHoulihan lokeyMichael milesSal aguirreRobert kalsow ramosJoanna rosePeter mintzbergWilliam blairWharton garrisonCredit suisseMizuho bankGlobal head of corporate communicationsDeutsche bankBetter worklife academyApollo global management inc

Bulletin from the Annual General Meeting in Oncopeptides AB (publ)

Bulletin from the Annual General Meeting in Oncopeptides AB (publ) News provided by Share this article Share this article STOCKHOLM, May 26, 2021 /PRNewswire/ The Annual General Meeting in Oncopeptides AB (publ) (ONCO) was held on Wednesday, 26 May 2021. At the Annual General Meeting, the following principal resolutions were passed. The presented annual report was adopted and the members of the Board of Directors and the CEO were discharged from liability in respect of the financial year 2020. It was resolved to carry forward the result for the year in accordance with the Board of Directors proposal. The proposed remunerations to the Board of Directors, its committees and the Company s auditor were approved.

United statesUlf jungneliusJennifer jacksonCecilia daun wennborgRolf gulliksenBrian stuglikLinda holmstrGlobal head of corporate communicationsAnnual general meetingJarl ulf jungneliusPer samuelssonNasdaq stockholmShare awardsGrant dateMain ownersStiftelsen industrifonden

Oncopeptides publishes report for Q1 2021 and updated dates for the publication of the reports for Q2 and Q3 2021

Oncopeptides publishes report for Q1 2021 and updated dates for the publication of the reports for Q2 and Q3 2021 A strong start for PEPAXTO in the US News provided by Share this article Share this article STOCKHOLM, May 26, 2021 /PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, has today published the report for the first quarter 2021. Oncopeptides now stands proudly among the few companies that have successfully navigated the long and difficult path from discovery to commercialization says CEO, Marty J Duvall. Financial overview January-March Operating loss amounted to SEK 347.3 M (loss: 296.9)

United statesMartyj duvallAnders martinRolf gulliksenKlaas bakkerLinda holmstrGlobal head of corporate communicationsNasdaq stockholmMultiple myeloma clinical practice guidelinesNational comprehensive cancer networkAnders martin lGlobal headCorporate communicationsInvestor relationsMid capஒன்றுபட்டது மாநிலங்களில்

Bulletin from the Annual General Meeting in Oncopeptides AB (publ)

Bulletin from the Annual General Meeting in Oncopeptides AB (publ)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesUlf jungneliusJennifer jacksonCecilia daun wennborgRolf gulliksenBrian stuglikLinda holmstrGlobal head of corporate communicationsAnnual general meetingJarl ulf jungneliusPer samuelssonNasdaq stockholmShare awardsGrant dateMain ownersStiftelsen industrifonden

Bulletin from the Annual General Meeting in Oncopeptides AB (publ)

Bulletin from the Annual General Meeting in Oncopeptides AB (publ)
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.